🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Terran Biosciences Receives FDA Clearance for MRI Scan Technology Terran gets FDA approval for NM-101, the industry’s first software for the analysis of neuromelanin-sensitive MRI microdose.buzz/news/terran-re…

Awakn signs global licensing agreement for exclusivity of proprietary S-ketamine oral film formulation $AWKN awaknlifesciences.com/awakn-enters-g…

We take a deeper look at ancient shamanic traditions, exploring how magic mushrooms may be a part of Christmas history microdose.buzz/news/exploring…

Microdose takes a look at the top psychedelic stories of 2023. Including: - Australia Legalization - Government Support for Psychedelics - MindMed's Phase 2b LSD Trial - Cybin's Phase 2 Trials for Depression - MAPS New Drug Application With FDA microdose.buzz/news/psychedel…

Atai Life Sciences Invests $50 Million into Beckley Psytech. The investment gives atai a 35.5% ownership share and exposure to Beckley's advanced trials. globenewswire.com/news-release/2…

Big News as MAPS PBC Rebrands to Lykos Therapeutics; Closes $100m Series A Funding lykospbc.com/2024/01/05/map…

In a new study, researchers from the Centre for Psychedelic Research at Imperial College London found that on average, people reported improvements across a range of areas of sexual function up to six months after their psychedelic experience, including their enjoyment of sex, sexual

We recently sat down with Sam Clark, MD PhD, CEO of Terran Biosciences, to discuss the exciting developments in their pipeline, particularly their latest schizophrenia therapeutic, TerXT. Read the full interview here: microdose.buzz/news/interview…

The FDA panel has rejected the first MDMA treatment for PTSD, citing serious concerns about the quality and reliability of the clinical trials conducted. nbcnews.com/health/health-…

Psyence Biomed Announces Acquisition of Psilocybin Drug Developer Clairvoyant Therapeutics Clairvoyant is running a Phase IIb clinical trial evaluating synthetic psilocybin for Alcohol Use Disorder (AUD) microdose.buzz/news/psyence-b…

Mindstate Design Labs AI-Designed Trial Gets FDA Approval Mindstate Design Labs has announced major news, receiving both FDA and European Medicines Agency (EMA) approval to commence human trials of its compound, MSD-001. microdose.buzz/news/mindstate…

In a powerful interview with Boston Magazine, actress Eliza Dushku shares her transformative journey with psychedelic-assisted therapy: bostonmagazine.com/news/2024/09/2…

Is aging contagious? Our latest interview with Scotch McClure, CEO of Maxwell Biosciences, explores groundbreaking theories that could reshape how we think about aging and health. Watch now on our website microdose.buzz/news/maxwell-b…

Scotch McClure from Maxwell Biosciences discusses reversing aging, pathogen-fighting peptides, and their implications for human health in our latest interview: microdose.buzz/news/maxwell-b…

Imagine a world where aging is reversible. CEO Scotch McClure explains how Maxwell Biosciences is pushing the boundaries of science to make it happen. Watch the full interview here: microdose.buzz/news/maxwell-b…

Is reversing aging the next big biotech breakthrough? Hear from Scotch McClure, CEO of Maxwell Biosciences, on how their research could transform health and longevity. microdose.buzz/news/maxwell-b…

What if we could replace antibiotics and antivirals with one solution? Scotch McClure from Maxwell Biosciences explores this exciting future in our latest interview: microdose.buzz/news/maxwell-b…

The future of health might lie in our microbiome. Learn how Scotch McClure and Maxwell Biosciences are unlocking the secrets to a longer, healthier life microdose.buzz/news/maxwell-b…

Synthetic immune systems could be the next big breakthrough in biotech. Hear from Scotch McClure, CEO of Maxwell Biosciences, on how they're leading the charge. Watch now: microdose.buzz/news/maxwell-b…

We sat down with Scotch McClure of Maxwell Biosciences to talk about disease prevention, reversing aging, and the future of health. This interview will change how you think about aging: microdose.buzz/news/maxwell-b…